Please login to the form below

Not currently logged in
Email:
Password:

crizotinib

This page shows the latest crizotinib news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Health and social care still divided, Opdivo rejected in bladder cancer, Xalkori extends reach

Daily Brief: Health and social care still divided, Opdivo rejected in bladder cancer, Xalkori extends reach

Expanded use of Xalkori approved in England. Also released today was final NICE guidance recommending Pfizer’s Xalkori (crizotinib) to treat ROS1-positive advanced non-small-cell lung cancer (NSCLC).

Latest news

More from news
Approximately 11 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    Xalkori: Symptom improvement and quality of life gains add benefit. In the case of Xalkori (crizotinib), Pfizer's product targeting a subsegment of non-small cell lung cancer (NSCLC) in which ... Outcome. Xalkori(crizotinib) in NSCLC. No OS benefit shown

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics